0
0
45 words
0
Comments
A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk for the disease.
You are the first to view
https://www.npr.org/sections/shots-health-news/2025/10/29/nx-s1-5575561/alzheimers-pill-apoe4-high-risk-lecanemab-donanemab
Create an account or login to join the discussion